P. Evans

发表

The effect of cimetidine, phenobarbitone and buthionine sulphoximine on the disposition of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulphonylamino) phenylamino]-4-acridinecarboxamide (CI-921) in the rabbit

J. Hardy, J. Paxton, P. Evans, 2004, Cancer Chemotherapy and Pharmacology.

Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921).

J. Hardy, V. Harvey, B. Baguley, 1988, Cancer research.

Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs

T. Gant, J. Ridings, N. Gooderham, 2017, Molecular therapy. Nucleic acids.

Disposition of amsacrine and its analogue 9-([2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921) in plasma, liver, and Lewis lung tumors in mice.

B. Baguley, P. Kestell, J. Paxton, 1990, Cancer research.

THIOLYTIC CLEAVAGE AND BINDING OF THE ANTITUMOUR AGENT CI-921 IN BLOOD

B. Baguley, P. Kestell, J. Paxton, 1988, Drug metabolism and drug interactions.